WHO ICTRP trial
Application of peripheral blood-derived stem cell (CD34?) therapy on chronic…
ISRCTN15592135 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN15592135 |
|---|---|
| Public title | Application of peripheral blood-derived stem cell (CD34?) therapy on chronic kidney disease |
| Scientific title | Application of peripheral blood-derived stem cell/progenitor cell (CD34?) therapy on chronic kidney disease: Phase 2 clinical trial |
| Primary sponsor | Ministry of Science and Technology, Taiwan |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Taiwan |
| Conditions | Chronic kidney disease Urological and Genital Diseases Chronic kidney disease |
| Interventions | Participants will be evenly divided into the intervention group and the controlled group using the envelope method. Participants in the intervention group will receive standard medication for chronic kidney disease, along with the… |
| Registration date | Aug 22, 2018 |
| Target size | 56 |
| Secondary IDs | TFDA No. 105IND04085 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: